COMMUNIQUÉS West-GlobeNewswire

-
RavenQuest Announces Media and Investor Open House at Edmonton Facility
29/06/2018 -
Sanofi: Availability of the Pre-quarterly Results Communication
29/06/2018 -
Sanofi : Mise en ligne du document «Pre-quarterly Results Communication »
29/06/2018 -
Shire plc : Rule 2.9 Announcement
29/06/2018 -
Chi-Med to Announce 2018 Half-Year Financial Results
29/06/2018 -
Dividend payment ex-date of AS “Olainfarm”
29/06/2018 -
NICOX : Point sur les récents progrès de ses programmes et activités clés
29/06/2018 -
Nicox Highlights Recent Progress with Key Programs and Activities
29/06/2018 -
Sensorion Shows Protective Effect of SENS-401 in Hearing Loss Models
29/06/2018 -
VALNEVA Announces Successful Outcome of its AGM and Renewal of the Term of Office of its Management Board Members
29/06/2018 -
VALNEVA annonce le succès de son Assemblée Générale et le renouvellement des mandats de son directoire
29/06/2018 -
Sanofi: CHMP recommends approval of Cablivi(TM) (caplacizumab)
29/06/2018 -
Sanofi : Le CHMP recommande l'approbation du Cablivi(TM) (caplacizumab)
29/06/2018 -
Novartis announces intention to seek shareholder approval for 100% spinoff of Alcon eye care devices business; initiates share buyback of up to USD 5 bn
29/06/2018 -
Novartis annonce son intention de solliciter l'approbation des actionnaires pour la scission à 100% d'Alcon, sa division de produits ophtalmologiques, et initie un rachat d'actions à hauteur d'USD ...
29/06/2018 -
Zomedica Announces Interim Closing and Extension of Its Private Offering of Common Shares
29/06/2018 -
Precision Therapeutics Signs Definitive Merger Agreement with Helomics Holding Corporation
29/06/2018 -
RavenQuest Announces Non-Brokered Private Placement
28/06/2018 -
GenMark Diagnostics Announces FDA Submission of its ePlex Blood Culture Identification Gram Positive Panel
28/06/2018
Pages